Literature DB >> 24752399

The role of Mss11 in Candida albicans biofilm formation.

Pei-Wen Tsai1, Yu-Ting Chen, Cheng-Yao Yang, Hsueh-Fen Chen, Te-Sheng Tan, Tzung-Wei Lin, Wen-Ping Hsieh, Chung-Yu Lan.   

Abstract

Candida albicans is an opportunistic human pathogen that can form a biofilm on biotic or inert surfaces such as epithelia and clinical devices. In this study, we examine the formation of C. albicans biofilm by establishing a key gene-centered network based on protein-protein interaction (PPI) and gene expression datasets. Starting from C. albicans Cph1 and Efg1, transcription factors associated with morphogenesis of biofilm formation, a network elucidates the complex cellular process and predicts potential unknown components related to biofilm formation. Subsequently, we analyzed the functions of Mss11 among these identified proteins to test the efficiency of the proposed computational approach. MSS11-deleted mutants were compared with a wild-type strain, indicating that the mutant is defective in forming a mature biofilm and partially attenuates the virulence of C. albicans in an infected mouse model. Finally, a DNA microarray analysis was conducted to identify the potential target genes of C. albicans Mss11. The findings of this study clarify complex gene or protein interaction during the biofilm formation process of C. albicans, supporting the application of a systems biology approach to study fungal pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24752399     DOI: 10.1007/s00438-014-0846-0

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  72 in total

1.  Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans.

Authors:  Luis A Murillo; George Newport; Chung-Yu Lan; Stefan Habelitz; Jan Dungan; Nina M Agabian
Journal:  Eukaryot Cell       Date:  2005-09

2.  Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay.

Authors:  Jeniel E Nett; Michael T Cain; Kyler Crawford; David R Andes
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

3.  Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development.

Authors:  Mohammed A S Alem; Mohammed D Y Oteef; T Hugh Flowers; L Julia Douglas
Journal:  Eukaryot Cell       Date:  2006-09-15

4.  Candida albicans Hap43 is a repressor induced under low-iron conditions and is essential for iron-responsive transcriptional regulation and virulence.

Authors:  Po-Chen Hsu; Cheng-Yao Yang; Chung-Yu Lan
Journal:  Eukaryot Cell       Date:  2010-12-03

5.  Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.

Authors:  J M Hornby; E C Jensen; A D Lisec; J J Tasto; B Jahnke; R Shoemaker; P Dussault; K W Nickerson
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

6.  A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

Authors:  Janghoo Lim; Tong Hao; Chad Shaw; Akash J Patel; Gábor Szabó; Jean-François Rual; C Joseph Fisk; Ning Li; Alex Smolyar; David E Hill; Albert-László Barabási; Marc Vidal; Huda Y Zoghbi
Journal:  Cell       Date:  2006-05-19       Impact factor: 41.582

7.  Network modeling links breast cancer susceptibility and centrosome dysfunction.

Authors:  Miguel Angel Pujana; Jing-Dong J Han; Lea M Starita; Kristen N Stevens; Muneesh Tewari; Jin Sook Ahn; Gad Rennert; Víctor Moreno; Tomas Kirchhoff; Bert Gold; Volker Assmann; Wael M Elshamy; Jean-François Rual; Douglas Levine; Laura S Rozek; Rebecca S Gelman; Kristin C Gunsalus; Roger A Greenberg; Bijan Sobhian; Nicolas Bertin; Kavitha Venkatesan; Nono Ayivi-Guedehoussou; Xavier Solé; Pilar Hernández; Conxi Lázaro; Katherine L Nathanson; Barbara L Weber; Michael E Cusick; David E Hill; Kenneth Offit; David M Livingston; Stephen B Gruber; Jeffrey D Parvin; Marc Vidal
Journal:  Nat Genet       Date:  2007-10-07       Impact factor: 38.330

8.  Hypoxic adaptation by Efg1 regulates biofilm formation by Candida albicans.

Authors:  Catrin Stichternoth; Joachim F Ernst
Journal:  Appl Environ Microbiol       Date:  2009-04-03       Impact factor: 4.792

9.  Candida biofilms and the host: models and new concepts for eradication.

Authors:  Hélène Tournu; Patrick Van Dijck
Journal:  Int J Microbiol       Date:  2011-11-14

10.  Portrait of Candida albicans adherence regulators.

Authors:  Jonathan S Finkel; Wenjie Xu; David Huang; Elizabeth M Hill; Jigar V Desai; Carol A Woolford; Jeniel E Nett; Heather Taff; Carmelle T Norice; David R Andes; Frederick Lanni; Aaron P Mitchell
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

View more
  6 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

Review 2.  Development and regulation of single- and multi-species Candida albicans biofilms.

Authors:  Matthew B Lohse; Megha Gulati; Alexander D Johnson; Clarissa J Nobile
Journal:  Nat Rev Microbiol       Date:  2017-10-03       Impact factor: 60.633

Review 3.  Candida albicans biofilms and polymicrobial interactions.

Authors:  Nicole O Ponde; Léa Lortal; Gordon Ramage; Julian R Naglik; Jonathan P Richardson
Journal:  Crit Rev Microbiol       Date:  2021-01-22       Impact factor: 7.624

4.  Role of SFP1 in the Regulation of Candida albicans Biofilm Formation.

Authors:  Hsueh-Fen Chen; Chung-Yu Lan
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

Review 5.  Protein-Protein Interactions in Candida albicans.

Authors:  Floris Schoeters; Patrick Van Dijck
Journal:  Front Microbiol       Date:  2019-08-07       Impact factor: 5.640

Review 6.  Transcriptional Circuits Regulating Developmental Processes in Candida albicans.

Authors:  Diana L Rodriguez; Morgan M Quail; Aaron D Hernday; Clarissa J Nobile
Journal:  Front Cell Infect Microbiol       Date:  2020-12-03       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.